Primary Care Clinics in Kokomo, IN Accepting Medicare
47 Primary Care Clinics found. Showing 41 - 47
 Healthy Children Healthy Teens Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 117 W Sycamore St, Kokomo, IN 46901 Phone: 765-453-8052 Fax: 765-864-8711 |
Ekg Interpretation Professionsals Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3505 S Reed Rd, Kokomo, IN 46902 Phone: 765-453-8668 Fax: 765-453-8506 |
Community Internists & Associates Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3505 S Reed Rd, Kokomo, IN 46902 Phone: 765-453-8666 Fax: 765-864-6785 |
Andrew J Mandery Md Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1948 W Boulevard, Kokomo, IN 46902 Phone: 765-236-1290 Fax: 765-236-0420 |
Meridian Health Services Corp. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 424 E Southway Blvd Ste 1, Kokomo, IN 46902 Phone: 765-288-1928 |
Verve Health At Howard County Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 620 N Bell St, Suite B, Kokomo, IN 46901 Phone: 765-456-7330 Fax: 765-456-2018 |
Ascension St. Vincent Kokomo Services Family Medicine Medicare: Medicare Enrolled Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5433 |
News Archive
Scripps Research receives NIH grant to develop therapies for circadian rhythm disorders
The Scripps Research Institute has been awarded $3.17 million over four years to develop compounds that will counteract disruptions of the human biological clock - the circadian rhythm that regulates our patterns of activity and rest over a 24-hour daily cycle.
Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.
MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform
MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.
New streamlined approach to genetic testing benefits women with ovarian cancer
A new streamlined approach to genetic testing for women with ovarian cancer provides testing rapidly and affordably, allowing many more patients to benefit from personalised cancer management and their relatives to benefit from cancer prevention strategies.
Clinical Xpert suite of mobile clinical workflow solutions available to clinicians
Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.
› Verified 2 days ago